Juniper Pharma (JNP) Tops Q3 EPS by 4c

Juniper Pharma (NASDAQ: JNP) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $13 million versus the consensus estimate of $12.55 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Reading (RDI) Tops Q2 EPS by 4c